nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—REN—autonomic nervous system—attention deficit hyperactivity disorder	0.114	0.17	CbGeAlD
Captopril—ACE—autonomic nervous system—attention deficit hyperactivity disorder	0.0484	0.0725	CbGeAlD
Captopril—LTA4H—forebrain—attention deficit hyperactivity disorder	0.0343	0.0514	CbGeAlD
Captopril—MMP2—Matrix Metalloproteinases—MMP16—attention deficit hyperactivity disorder	0.0307	0.0923	CbGpPWpGaD
Captopril—MMP2—Activation of Matrix Metalloproteinases—MMP16—attention deficit hyperactivity disorder	0.0292	0.0876	CbGpPWpGaD
Captopril—LTA4H—cardiovascular system—attention deficit hyperactivity disorder	0.029	0.0435	CbGeAlD
Captopril—REN—forebrain—attention deficit hyperactivity disorder	0.0265	0.0397	CbGeAlD
Captopril—LTA4H—midbrain—attention deficit hyperactivity disorder	0.0227	0.0339	CbGeAlD
Captopril—REN—cardiovascular system—attention deficit hyperactivity disorder	0.0224	0.0335	CbGeAlD
Captopril—MMP2—cardiovascular system—attention deficit hyperactivity disorder	0.0206	0.0308	CbGeAlD
Captopril—MMP9—Matrix Metalloproteinases—MMP16—attention deficit hyperactivity disorder	0.0201	0.0605	CbGpPWpGaD
Captopril—MMP9—Activation of Matrix Metalloproteinases—MMP16—attention deficit hyperactivity disorder	0.0191	0.0575	CbGpPWpGaD
Captopril—LTA4H—nervous system—attention deficit hyperactivity disorder	0.0186	0.0279	CbGeAlD
Captopril—LTA4H—central nervous system—attention deficit hyperactivity disorder	0.0179	0.0269	CbGeAlD
Captopril—MMP9—cardiovascular system—attention deficit hyperactivity disorder	0.0179	0.0268	CbGeAlD
Captopril—LTA4H—cerebellum—attention deficit hyperactivity disorder	0.0175	0.0263	CbGeAlD
Captopril—MMP2—midbrain—attention deficit hyperactivity disorder	0.0161	0.0241	CbGeAlD
Captopril—F2—cardiovascular system—attention deficit hyperactivity disorder	0.0156	0.0234	CbGeAlD
Captopril—REN—nervous system—attention deficit hyperactivity disorder	0.0144	0.0215	CbGeAlD
Captopril—LTA4H—brain—attention deficit hyperactivity disorder	0.0142	0.0213	CbGeAlD
Captopril—REN—central nervous system—attention deficit hyperactivity disorder	0.0138	0.0207	CbGeAlD
Captopril—REN—cerebellum—attention deficit hyperactivity disorder	0.0135	0.0203	CbGeAlD
Captopril—MMP2—nervous system—attention deficit hyperactivity disorder	0.0132	0.0198	CbGeAlD
Captopril—MMP2—Degradation of the extracellular matrix—MMP16—attention deficit hyperactivity disorder	0.0129	0.0387	CbGpPWpGaD
Captopril—MMP2—central nervous system—attention deficit hyperactivity disorder	0.0127	0.0191	CbGeAlD
Captopril—F2—Platelet Aggregation (Plug Formation)—ADRA2C—attention deficit hyperactivity disorder	0.0123	0.0369	CbGpPWpGaD
Captopril—MMP9—nervous system—attention deficit hyperactivity disorder	0.0115	0.0172	CbGeAlD
Captopril—ACE—forebrain—attention deficit hyperactivity disorder	0.0113	0.0169	CbGeAlD
Captopril—MMP9—central nervous system—attention deficit hyperactivity disorder	0.0111	0.0166	CbGeAlD
Captopril—REN—brain—attention deficit hyperactivity disorder	0.011	0.0165	CbGeAlD
Captopril—MMP2—brain—attention deficit hyperactivity disorder	0.0101	0.0151	CbGeAlD
Captopril—F2—nervous system—attention deficit hyperactivity disorder	0.01	0.015	CbGeAlD
Captopril—F2—central nervous system—attention deficit hyperactivity disorder	0.00965	0.0145	CbGeAlD
Captopril—ACE—cardiovascular system—attention deficit hyperactivity disorder	0.00954	0.0143	CbGeAlD
Captopril—MMP9—brain—attention deficit hyperactivity disorder	0.00878	0.0132	CbGeAlD
Captopril—MMP9—Degradation of the extracellular matrix—MMP16—attention deficit hyperactivity disorder	0.00844	0.0254	CbGpPWpGaD
Captopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A9—attention deficit hyperactivity disorder	0.00839	0.0252	CbGpPWpGaD
Captopril—SLC22A6—brain—attention deficit hyperactivity disorder	0.00785	0.0118	CbGeAlD
Captopril—F2—brain—attention deficit hyperactivity disorder	0.00766	0.0115	CbGeAlD
Captopril—F2—Platelet Aggregation (Plug Formation)—ADRA2A—attention deficit hyperactivity disorder	0.00645	0.0194	CbGpPWpGaD
Captopril—ACE—nervous system—attention deficit hyperactivity disorder	0.00612	0.00918	CbGeAlD
Captopril—MMP9—Spinal Cord Injury—RTN4—attention deficit hyperactivity disorder	0.00604	0.0182	CbGpPWpGaD
Captopril—ACE—central nervous system—attention deficit hyperactivity disorder	0.0059	0.00883	CbGeAlD
Captopril—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00552	0.00827	CbGeAlD
Captopril—MMP2—Extracellular matrix organization—MMP16—attention deficit hyperactivity disorder	0.00539	0.0162	CbGpPWpGaD
Captopril—ALB—brain—attention deficit hyperactivity disorder	0.00489	0.00733	CbGeAlD
Captopril—ACE—brain—attention deficit hyperactivity disorder	0.00468	0.00701	CbGeAlD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—attention deficit hyperactivity disorder	0.00435	0.0131	CbGpPWpGaD
Captopril—MMP2—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00418	0.0126	CbGpPWpGaD
Captopril—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00397	0.00595	CbGeAlD
Captopril—MMP2—FOXM1 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00393	0.0118	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00375	0.0113	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—MMP16—attention deficit hyperactivity disorder	0.00353	0.0106	CbGpPWpGaD
Captopril—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00336	0.00503	CbGeAlD
Captopril—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.003	0.00449	CbGeAlD
Captopril—MMP2—ATF-2 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00299	0.00899	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00299	0.00898	CbGpPWpGaD
Captopril—MMP2—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00295	0.00886	CbGpPWpGaD
Captopril—LTA4H—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00294	0.00885	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00294	0.00883	CbGpPWpGaD
Captopril—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00289	0.00432	CbGeAlD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—attention deficit hyperactivity disorder	0.00285	0.00857	CbGpPWpGaD
Captopril—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00282	0.00423	CbGeAlD
Captopril—SLC22A6—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00278	0.00837	CbGpPWpGaD
Captopril—MMP9—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00274	0.00825	CbGpPWpGaD
Captopril—MMP2—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.0027	0.00811	CbGpPWpGaD
Captopril—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00262	0.00393	CbGeAlD
Captopril—F2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00252	0.00759	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—BDNF—attention deficit hyperactivity disorder	0.00252	0.00757	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—attention deficit hyperactivity disorder	0.00234	0.00705	CbGpPWpGaD
Captopril—CYP2D6—brain—attention deficit hyperactivity disorder	0.00229	0.00343	CbGeAlD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00222	0.00668	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00218	0.00655	CbGpPWpGaD
Captopril—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00216	0.00323	CbGeAlD
Captopril—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.00213	0.00641	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.0021	0.00632	CbGpPWpGaD
Captopril—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00208	0.00311	CbGeAlD
Captopril—LTA4H—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00203	0.00611	CbGpPWpGaD
Captopril—LTA4H—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00203	0.00611	CbGpPWpGaD
Captopril—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00203	0.00304	CbGeAlD
Captopril—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00203	0.0061	CbGpPWpGaD
Captopril—LTA4H—Metabolism—DPYD—attention deficit hyperactivity disorder	0.002	0.00601	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00196	0.00589	CbGpPWpGaD
Captopril—MMP9—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00193	0.00581	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00192	0.00578	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.0019	0.00573	CbGpPWpGaD
Captopril—LTA4H—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00186	0.00559	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00182	0.00546	CbGpPWpGaD
Captopril—MMP9—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.00177	0.00532	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—EP300—attention deficit hyperactivity disorder	0.00171	0.00515	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00169	0.00509	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00166	0.00499	CbGpPWpGaD
Captopril—ABCB1—brain—attention deficit hyperactivity disorder	0.00165	0.00247	CbGeAlD
Captopril—LTA4H—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00162	0.00489	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—EP300—attention deficit hyperactivity disorder	0.00155	0.00467	CbGpPWpGaD
Captopril—LTA4H—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00155	0.00465	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00154	0.00464	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—attention deficit hyperactivity disorder	0.00154	0.00462	CbGpPWpGaD
Captopril—F2—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00151	0.00455	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00151	0.00454	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—EP300—attention deficit hyperactivity disorder	0.0015	0.00451	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00145	0.00435	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00143	0.00429	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00141	0.00425	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00138	0.00415	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00135	0.00406	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00132	0.00397	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.0013	0.00392	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0013	0.0039	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00126	0.00379	CbGpPWpGaD
Captopril—LTA4H—Metabolism—COMT—attention deficit hyperactivity disorder	0.00123	0.0037	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00123	0.00369	CbGpPWpGaD
Captopril—LTA4H—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00122	0.00368	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00119	0.00357	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00119	0.00357	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00117	0.00351	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00117	0.0035	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00115	0.00347	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00115	0.00346	CbGpPWpGaD
Captopril—F2—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00114	0.00342	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00107	0.00323	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00102	0.00306	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.001	0.00302	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000991	0.00298	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000968	0.00291	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000957	0.00288	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000937	0.00282	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000934	0.00281	CbGpPWpGaD
Captopril—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000919	0.00276	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000905	0.00272	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000889	0.00267	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000878	0.00264	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000869	0.00261	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000851	0.00256	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000818	0.00246	CbGpPWpGaD
Captopril—F2—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000795	0.00239	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000774	0.00233	CbGpPWpGaD
Captopril—F2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000765	0.0023	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000753	0.00226	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000735	0.00221	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000701	0.00211	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000665	0.002	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000663	0.00199	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000651	0.00196	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00065	0.00195	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000644	0.00194	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000639	0.00192	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000614	0.00185	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.000612	0.00184	CbGpPWpGaD
Captopril—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000601	0.00181	CbGpPWpGaD
Captopril—F2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000597	0.0018	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00059	0.00177	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000573	0.00172	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000568	0.00171	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000547	0.00164	CbGpPWpGaD
Captopril—LTA4H—Metabolism—EP300—attention deficit hyperactivity disorder	0.000528	0.00159	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000528	0.00159	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000516	0.00155	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000513	0.00154	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000511	0.00154	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000503	0.00151	CbGpPWpGaD
Captopril—F2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000503	0.00151	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000503	0.00151	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000496	0.00149	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000493	0.00148	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000492	0.00148	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000492	0.00148	CbGpPWpGaD
Captopril—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000488	0.00147	CbGpPWpGaD
Captopril—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000485	0.00146	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000482	0.00145	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000479	0.00144	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000464	0.0014	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000462	0.00139	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00046	0.00138	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000456	0.00137	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000451	0.00136	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000451	0.00136	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00042	0.00126	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000395	0.00119	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000367	0.0011	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000358	0.00108	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000355	0.00107	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000349	0.00105	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000349	0.00105	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000345	0.00104	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000324	0.000974	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000321	0.000966	CbGpPWpGaD
Captopril—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000316	0.000949	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000305	0.000916	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000294	0.000884	CbGpPWpGaD
Captopril—F2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000283	0.000852	CbGpPWpGaD
Captopril—F2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000274	0.000825	CbGpPWpGaD
Captopril—F2—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000272	0.000816	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00027	0.000811	CbGpPWpGaD
Captopril—F2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000266	0.000801	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000256	0.000769	CbGpPWpGaD
Captopril—F2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000248	0.000746	CbGpPWpGaD
Captopril—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000244	0.000732	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000225	0.000677	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000224	0.000674	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000213	0.000642	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000206	0.000619	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000201	0.000605	CbGpPWpGaD
Captopril—F2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000174	0.000522	CbGpPWpGaD
Captopril—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000168	0.000505	CbGpPWpGaD
Captopril—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000168	0.000505	CbGpPWpGaD
Captopril—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000165	0.000497	CbGpPWpGaD
Captopril—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000154	0.000462	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000147	0.000443	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000147	0.000443	CbGpPWpGaD
Captopril—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000145	0.000436	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000139	0.000417	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000139	0.000417	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000137	0.000411	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000135	0.000405	CbGpPWpGaD
Captopril—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000134	0.000404	CbGpPWpGaD
Captopril—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000128	0.000385	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000127	0.000382	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000119	0.000358	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000118	0.000354	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000112	0.000337	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000111	0.000334	CbGpPWpGaD
Captopril—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000108	0.000324	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000106	0.000318	CbGpPWpGaD
Captopril—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	0.000102	0.000306	CbGpPWpGaD
Captopril—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000101	0.000304	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	9.81e-05	0.000295	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	9.21e-05	0.000277	CbGpPWpGaD
Captopril—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	8.92e-05	0.000268	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.86e-05	0.000266	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	8.41e-05	0.000253	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	8.35e-05	0.000251	CbGpPWpGaD
Captopril—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	4.37e-05	0.000131	CbGpPWpGaD
Captopril—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	3.83e-05	0.000115	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	3.61e-05	0.000108	CbGpPWpGaD
